HT
GSK icon

HighTower Trust’s GSK GSK Stock Holding History

HighTower Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,740
Closed -$539K – 108
2018
Q3 		$539K Sell
10,740
-2,000
-16% -$102K 0.06% 86
2018
Q2 		$642K Sell
12,740
-124
-1% -$6.25K 0.07% 94
2018
Q1 		$628K Sell
12,864
-1,358
-10% -$63.2K 0.08% 88
2017
Q4 		$631K Buy
14,222
+4,050
+40% +$187K 0.07% 92
2017
Q3 		$516K Sell
10,172
-4,360
-30% -$221K 0.06% 74
2017
Q2 		$783K Sell
14,532
-196
-1% -$10.4K 0.09% 71
2017
Q1 		$776K Buy
14,728
+1,592
+12% +$80.8K 0.09% 84
2016
Q4 		$632K Sell
13,136
-8
-0.1% -$395 0.07% 97
2016
Q3 		$709K Buy
13,144
+4,188
+47% +$230K 0.08% 85
2016
Q2 		$485K Buy
+8,956
New +$472K 0.05% 104

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

HighTower Trust's GSK Position: Q4 2018 in Review

HighTower Trust sold out of GSK (GSK) in Q4 2018, closing a stake of 10,740 shares — an estimated $539K sold.

HighTower Trust first reported a position in GSK in Q2 2016 and held it in 10 quarters. The position peaked at $783K in Q2 2017. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

  • HighTower Trust reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
  • HighTower Trust sold 10,740 GSK shares in Q4 2018, an estimated $539K.
  • HighTower Trust first reported a position in GSK in Q2 2016 and held it in 10 quarters.
  • HighTower Trust's GSK position peaked at $783K in Q2 2017.
  • 799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on HighTower Trust's 13F filing for Q4 2018, filed 28 Jan 2019.